Creative Medical Technology (CELZ) Expected to Announce Quarterly Earnings on Friday

Creative Medical Technology (NASDAQ:CELZ) is anticipated to issue its quarterly earnings data before the market opens on Friday, March 28th. Analysts expect the company to announce earnings of ($0.63) per share for the quarter.

Creative Medical Technology Trading Down 8.3 %

NASDAQ:CELZ opened at $2.78 on Friday. Creative Medical Technology has a 1 year low of $1.96 and a 1 year high of $6.90. The firm has a 50 day moving average of $3.75 and a 200-day moving average of $3.27. The stock has a market capitalization of $6.46 million, a P/E ratio of -0.73 and a beta of 1.69.

Creative Medical Technology Company Profile

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.